AU7537494A - Living (salmonella) vaccine - Google Patents

Living (salmonella) vaccine

Info

Publication number
AU7537494A
AU7537494A AU75374/94A AU7537494A AU7537494A AU 7537494 A AU7537494 A AU 7537494A AU 75374/94 A AU75374/94 A AU 75374/94A AU 7537494 A AU7537494 A AU 7537494A AU 7537494 A AU7537494 A AU 7537494A
Authority
AU
Australia
Prior art keywords
salmonella
vaccine
living
marker
host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU75374/94A
Other versions
AU687861B2 (en
Inventor
Jorg Beer
Klaus Linde
Barbel Randhagen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lohmann Animal Health GmbH and Co KG
Original Assignee
Lohmann Animal Health GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Animal Health GmbH and Co KG filed Critical Lohmann Animal Health GmbH and Co KG
Publication of AU7537494A publication Critical patent/AU7537494A/en
Application granted granted Critical
Publication of AU687861B2 publication Critical patent/AU687861B2/en
Assigned to LOHMANN ANIMAL HEALTH GMBH & CO. KG reassignment LOHMANN ANIMAL HEALTH GMBH & CO. KG Alteration of Name(s) of Applicant(s) under S113 Assignors: TAD PHARMAZEUTISCHES WERK GMBH
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The use of at least one attenuated immunogenic salmonella live vaccine strain which is provided with a marker (envelope marker) conferring sensitivity to macrolide antibiotics for the production of a live vaccine for a particular host which, in the case of an infection of another host caused by the first, allows effective therapeutic treatment of the infected host using macrolides.
AU75374/94A 1993-09-04 1994-08-29 Living (salmonella) vaccine Expired AU687861B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP93114221 1993-04-09
EP93114221A EP0642796B1 (en) 1993-09-04 1993-09-04 Salmonella live vaccines
PCT/EP1994/002858 WO1995007101A2 (en) 1993-09-04 1994-08-29 Living salmonella vaccine

Publications (2)

Publication Number Publication Date
AU7537494A true AU7537494A (en) 1995-03-27
AU687861B2 AU687861B2 (en) 1998-03-05

Family

ID=8213234

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75374/94A Expired AU687861B2 (en) 1993-09-04 1994-08-29 Living (salmonella) vaccine

Country Status (14)

Country Link
EP (1) EP0642796B1 (en)
JP (1) JP2838098B2 (en)
CN (1) CN1097466C (en)
AT (1) ATE209929T1 (en)
AU (1) AU687861B2 (en)
BR (1) BR9405578A (en)
CA (1) CA2131231C (en)
DE (3) DE59310244D1 (en)
DK (1) DK0642796T3 (en)
ES (1) ES2168265T3 (en)
NL (1) NL300092I2 (en)
PT (1) PT642796E (en)
RU (1) RU2177804C2 (en)
WO (1) WO1995007101A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136325A (en) * 1993-04-09 2000-10-24 Lohmann Animal Health Gmbh & Co. Kg Live vaccine constituting minor risk for humans
DE202004006282U1 (en) 2004-04-19 2004-07-01 Lohmann Animal Health Gmbh & Co. Kg Device for the sensitivity test of bacterial infectious agents and vaccine strains of poultry
DE102007012824A1 (en) * 2007-03-17 2008-09-18 Universität Leipzig Vaccine strains with graded colony size/attenuation comprise at least two attenuating metabolic drift mutations that are resistance mutations
DE102008062941A1 (en) * 2008-12-23 2010-07-01 Universität Leipzig New vaccine strains having two or three different attenuation active metabolic drift mutations, which result in smaller colonies with corresponding longer generation time and correlated attenuation degree
WO2014037445A1 (en) * 2012-09-05 2014-03-13 Lohmann Animal Health Gmbh Preparation of live vaccines
WO2014037103A1 (en) 2012-09-05 2014-03-13 Universität Leipzig Live attenuated metabolic drift vaccine against fowl typhoid
JP6336461B2 (en) * 2012-12-07 2018-06-06 ローマン・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＬｏｈｍａｎｎ Ａｎｉｍａｌ Ｈｅａｌｔｈ ＧｍｂＨ Preparation of live vaccine
RU2750865C1 (en) * 2020-04-09 2021-07-05 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук" (ФГБНУ ФНЦ ВИЭВ РАН) Polyvalent inactivated vaccine against riemerellosis, pasteurellosis and salmonellosis of turkeys, ducks and geese, the method of its preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2843295A1 (en) * 1978-10-04 1980-10-30 Inst Impfstoffe Dessau Prodn. of bacterial mutants for live vaccines - by selecting purine-dependent clones
DE3751641D1 (en) * 1986-10-10 1996-02-01 Tad Pharm Werk Live Salmonella vaccines with host species-adjusted attenuation levels and anti-epidemic potency

Also Published As

Publication number Publication date
DK0642796T3 (en) 2002-01-21
CN1114100A (en) 1995-12-27
PT642796E (en) 2002-05-31
WO1995007101A2 (en) 1995-03-16
NL300092I1 (en) 2002-08-01
WO1995007101A3 (en) 1995-04-27
JP2838098B2 (en) 1998-12-16
JPH07206706A (en) 1995-08-08
CA2131231A1 (en) 1995-03-05
BR9405578A (en) 1999-09-08
EP0642796B1 (en) 2001-12-05
NL300092I2 (en) 2002-12-02
RU2177804C2 (en) 2002-01-10
AU687861B2 (en) 1998-03-05
ES2168265T3 (en) 2002-06-16
DE59310244D1 (en) 2002-01-17
DE4496626D2 (en) 1996-06-27
CA2131231C (en) 1999-01-19
ATE209929T1 (en) 2001-12-15
CN1097466C (en) 2003-01-01
DE10299020I1 (en) 2002-11-07
RU95112808A (en) 1997-03-20
DE10299020I2 (en) 2007-12-27
EP0642796A1 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
LV10203A (en) A test-kit of a protein composition for the detection of infections with AIDS
WO2000004919A3 (en) Live attenuated salmonella vaccines to control avian pathogens
PT877624E (en) STREPTOCOCCAL PEPTIDASE C5A VACCINE
WO1995007101A3 (en) Living salmonella vaccine
DE3586841T2 (en) ORAL Vaccines.
ES8802209A1 (en) Vaccine system
AU1747688A (en) Canine coronavirus vaccine
NZ195184A (en) Live feline infectious peritonitis (fip) virus vaccine; fip virus atcc no.vr-2004
IE44911L (en) Rhinotracheitis vaccine.
DE3686158D1 (en) VACCINE AGAINST MASTITIS.
EP0166548A3 (en) Broad spectrum vaccine against gonorrhea
DE69824794D1 (en) Streptococcus equi vaccine
HUP9700975A2 (en) Live attenuated rtx-producing bacteria of the family pasteurellaceae
ES476703A1 (en) Heterovaccine against the trichomonas syndrome, and process for its preparation
AU1081283A (en) Ozone inactivated organisms as vaccines
AU2293188A (en) Vaccine for protection of cats against feline infectious peritonitis
DE69708425D1 (en) Macrophage infecting parasites that express a leukocyte and macrophage stimulating hormone
WO2002074287A3 (en) Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics
DK445987A (en) SWALPAMYCIN, PREPARATION OF IT AND ITS USE AS A MEDICINE, AND MICROorganism APPLICABLE TO THE PREPARATION
FI864769A (en) ICKE ADJUVANSERAD VACCIN.
ATE84722T1 (en) RABIES LIVE VACCINE.
AU8007391A (en) Vaccine composition for treating human chlamydial diseases
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
PINTO Efficacy of the Heat-Labile Enterotoxin from Escherichia Coli as an Adjuvant for a HSV-2 Inactivated Oral Vaccine(Final Report, 1 Jun. 1993- 31 Mar. 1996)
Shikatani et al. Clinical effect of 0. 3% norfloxacin ophthalmic solution for external bacterial infection.